Français
ItalianoBond Amgen 2.77% ( US031162CY49 ) in USD
| Issuer | Amgen | ||||||||||
| Market price |  59.51 % ▼ |
||||||||||
| Country |  United States
|
||||||||||
| ISIN code |
 US031162CY49 ( in USD )
|
||||||||||
| Interest rate | 2.77% per year ( payment 2 times a year) | ||||||||||
| Maturity | 01/09/2053 | ||||||||||
|
Prospectus brochure in PDF format |
|||||||||||
| Minimal amount | 2 000 USD | ||||||||||
| Total amount | 939 919 000 USD | ||||||||||
| Cusip | 031162CY4 | ||||||||||
| Standard & Poor's ( S&P ) rating | BBB+ ( Lower medium grade - Investment-grade ) | ||||||||||
| Moody's rating | Baa1 ( Lower medium grade - Investment-grade ) | ||||||||||
| Next Coupon | 01/03/2027 ( In 168 days ) | ||||||||||
| Detailed description |
Amgen is a leading biotechnology company focused on developing and delivering innovative therapies for serious illnesses in areas such as oncology, cardiovascular disease, and inflammation. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CY49, pays a coupon of 2.77% per year. The coupons are paid 2 times per year and the Bond maturity is 01/09/2053 The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CY49, was rated Baa1 ( Lower medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Amgen ( United States ) , in USD, with the ISIN code US031162CY49, was rated BBB+ ( Lower medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||||||
| |||||||||||